Showing results (81-90 of 163) with videos related to
Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
Plasma tetranectin and colorectal cancerC K Høgdall, M Christiansen, B Nørgaard-Pedersen, et al.Acta Medica Scandinavica|January 1, 1979
Thrombotic thrombocytopenic purpura: treatment with a combination of antiplatelet drugsH Birgens, P Ernst, M S HansenScandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patientsC K Høgdall, E V Høgdall, U Hørding, et al.Histopathology|November 1, 1994
Tetranectin expression in human colonic neoplasiaH W Verspaget, I Clemmensen, S Ganesh, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|February 17, 1997
Monoclonal antibodies against human tetranectin, epitope characterization and use in immunohistochemistryC K Høgdall, M Christiansen, L Christensen, et al.Scandinavian Journal of Haematology|September 1, 1979
The effect of acetyl salicylic acid and dipyridamole on thromboembolic complications in splenectomized patients with myelofibrosisM S Hansen, B E Christensen, V JønssonGynecologic Oncology|November 1, 1991
Plasma tetranectin and ovarian neoplasmsC K Høgdall, E V Høgdall, U Hørding, et al.Thrombosis and Haemostasis|September 29, 1989
Quantitation of plasma levels of tetranectin--effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosisC Kluft, P Los, I Clemmensen, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Use of tetranectin, CA-125 and CASA to predict residual tumor and survival at second- and third-look operations for ovarian cancerC K Høgdall, E V Høgdall, U Hørding, et al.The Science of the Total Environment|March 26, 2015
Secondary formation of disinfection by-products by UV treatment of swimming pool waterAikaterini Spiliotopoulou, Kamilla M S Hansen, Henrik R AndersenPageof 17